What was found when the risk for diabetes or diabetes nephropathy was assessed in our study was that carriers of at least one GSTO1 rs4925 variant allele (*CA+ AA) were less prone to T2DM development. This evidence concerns the gene GSTO1 and type 2 diabetes mellitus.